Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5500 CAD | 0.00% |
|
-9.84% | -21.43% |
| 13/05 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 13/05 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 9.75Cr 8.58Cr 7.97Cr 7.33Cr 14Cr 944.66Cr 14Cr 95Cr 37Cr 460.76Cr 37Cr 36Cr 1.6TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 9.92Cr 9.22Cr 8.48Cr 16Cr 1.09TCr 16Cr 110.25Cr 43Cr 533.03Cr 42Cr 41Cr 1.85TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 week | -9.84% | ||
| Current month | -1.79% | ||
| 1 month | -8.33% | ||
| 3 months | +3.77% | ||
| 6 months | -3.51% | ||
| Current year | -21.43% |
| 1 week | 0.53 |  | 0.64 |
| 1 month | 0.51 | | 0.69 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.22 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/04/26 | Buy | Chief Financial Officer | 1,400 | 0.0006% | ||
| 20/01/26 | Mindset Capital LLC
| Buy | Company | 50,000 | 0.0200% | |
| 20/01/26 | Mindset Capital LLC
| Buy | Company | 65,700 | 0.0263% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -9.84% | 0.00% | +124.49% | 9.75Cr | |
| -0.10% | -0.79% | -8.54% | -3.35% | 1.36TCr | |
| -0.65% | -4.12% | -28.73% | -50.29% | 522.78Cr | |
| -0.31% | -0.23% | +0.57% | -1.00% | 483.15Cr | |
| -1.74% | -2.53% | +7.97% | -30.00% | 417.82Cr | |
| -0.45% | -3.65% | +3.42% | -7.77% | 370.78Cr | |
| -1.64% | +2.93% | -2.10% | -1.75% | 367.65Cr | |
| -0.31% | +0.13% | -1.42% | +12.88% | 351.78Cr | |
| -1.25% | -2.29% | -11.58% | -21.43% | 245.98Cr | |
| +0.85% | -1.91% | -3.29% | +49.54% | 187.98Cr | |
| Average | -0.56% | +0.29% | -4.37% | +7.13% | 431.95Cr | |
| Weighted average by Cap. | -0.55% | +1.15% | -6.14% | -8.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.38Cr 2.21Cr 2.03Cr 3.81Cr 261.64Cr 3.88Cr 26Cr 10Cr 127.62Cr 10Cr 9.92Cr 442.74Cr | 3.24Cr 2.85Cr 2.65Cr 2.44Cr 4.57Cr 314.04Cr 4.65Cr 32Cr 12Cr 153.17Cr 12Cr 12Cr 531.41Cr |
| Net income | -1.13Cr -99.42L -92.36L -84.94L -1.59Cr -109.47Cr -1.62Cr -11Cr -4.31Cr -53Cr -4.24Cr -4.15Cr -185.24Cr | 17.3L 15.21L 14.13L 13L 24.38L 17Cr 24.81L 1.69Cr 65.92L 8.17Cr 64.94L 63.54L 28Cr |
| Net Debt | 37.04L 32.58L 30.27L 27.84L 52.2L 36Cr 53.14L 3.62Cr 1.41Cr 17Cr 1.39Cr 1.36Cr 61Cr | 1.53Cr 1.35Cr 1.25Cr 1.15Cr 2.16Cr 148.16Cr 2.19Cr 15Cr 5.83Cr 72Cr 5.74Cr 5.62Cr 250.72Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | CA$0.5500 | -1.79% | 87,860 |
| 22/26/22 | CA$0.5600 | -5.08% | 17,000 |
| 21/26/21 | CA$0.5900 | -1.67% | 6,293 |
| 20/26/20 | CA$0.6000 | -3.23% | 11,900 |
| 17/26/17 | CA$0.6200 | +1.64% | 9,006 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
